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ㅋ
The irritable bowel syndrome (IBS) is the best known of the functional gastrointestinal tract disorders. Many IBS patients have 
at least one co-morbid somatic complaint and many meet diagnostic criteria for other functional disorders. Patients with IBS 
and another functional disorder, in comparison with patients with IBS only, have more severe IBS symptoms, a higher rate of 
psychopathology, greater impairment of quality of life, and more illness-related work absenteeism. Estimates of the prevalence 
of IBS in patients with fibromyalgia range from 30-35% to as high as 70%. Studies of IBS among patients with chronic fa-
tigue syndrome have reported a prevalence ranging from 35-92%. The prevalence of IBS among patients with chronic fatigue 
syndrome is reported to be 14%. IBS patients with other co-morbid functional disorders appear to manifest a greater degree 
of somatization. It has been suggested that the presence of multiple co-morbid disorders may be a marker for psychological 
influences on etiology. This raises the question of whether the functional syndromes represent the same pathophysiological 
process, i.e., are the same entity that has been separated into different clinical entities because of medical sub-specialization, 
or are indeed separate disorders. While the answer to this question awaits further research, it would appear that most func-
tional patients who meet formal diagnostic criteria for more than one functional disorder manifest one disorder clinically more 
that the others and seek consultation differentially for that set of symptoms.
(J Neurogastroenterol Motil 2010;16:113-119)
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Introduction
The irritable bowel syndrome (IBS) is the best known of the 
functional gastrointestinal tract disorders (FGID), all charac-
terized by chronic or recurrent gastrointestinal tract symptoms 
not explained by structural abnormalities, infection, or metabolic 
changes on routine testing.
1 Patients with IBS suffer from chron-
ic abdominal pain, usually in the lower abdomen, with a disturbed 
bowel pattern, which can be constipation, diarrhea or alternating 
constipation and diarrhea. Although the range of prevalence rates 
for IBS in studies conducted throughout the world is broad (from 
2-25%), in the Western world it is generally agreed that 10-20% 
of adults meet diagnostic criteria for IBS.
2,3 Approximately Ami D. Sperber and Roy Dekel
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Table 1. Co-morbid Functional Syndromes and Common 
Unexplained Symptoms
Co-morbid functional syndromes
    Other functional GI disorders
    Fibromyalgia
    Chronic fatigue syndrome
    Multiple chemical sensitivity syndrome
    Post-traumatic stress disorder
    Chronic pelvic pain
    Psychological co-morbidity
      Somatization disorder
      Depression
      Anxiety
      Panic disorder
    Interstitial cystitis and dysuria
    Migraine and tension headaches
    Temperomandibular joint disorder
    Sexual-related disorders
      Dyspareunia
      Exacerbation of IBS during menses
      Decreased libido
Common unexplained symptoms
    Sleeping problems
    Muscle pain
    Fatigue
    Headache
    Dizziness
    Palpitations
    Back pain
    Shortness of breath
    Dry mouth
GI, gastrointestinal; IBS, irritable bowel syndrome.
60-70% of IBS patients are women, making it a serious women’s 
health concern.
Systematic reviews of the literature on the co-morbidity of 
IBS and somatic and psychological disorders have been pub-
lished over the last decade or so.
4,5 Whitehead et al.
4 found that 
50% of IBS patients have at least one co-morbid somatic com-
plaint and many IBS patients meet diagnostic criteria for other 
functional disorders. There is substantial overlap between IBS 
and other FGID, such as functional dyspepsia. Significantly, pa-
tients with IBS and another functional disorder, in comparison 
with patients with IBS only, have more severe IBS symptoms, a 
higher rate of psychopathology such as depression, anxiety and 
somatization, greater impairment of quality of life, and more ill-
ness-related work absenteeism.
6,7
In another systematic review Riedl et al.
5 found that IBS pa-
tients have a 2-fold increase in co-morbidities, both gastro-
intestinal and extraintestinal, and that patients with co-morbidity 
have more impaired quality of life. 
Table 1 presents a list of functional disorders in various body 
systems and unexplained symptoms that are common in patients 
with functional disorders and are often considered to be manifes-
tations of multiple system complaints or somatization.
8-10 The 
various functional disorders have important characteristics in 
common, including epidemiology (female predominance), patho-
physiology (inflammation, hypersensitivity, impaired central 
processing of afferent sensory information, role of serotonin, psy-
chological distress and somatization, and the role of stress and life 
events), diagnosis (symptom-based), the central role of the pa-
tient-physician relationship in therapy, and common therapeutic 
modalities.
The next sections present data on associations between IBS 
and (1) other gastrointestinal disorders, (2) extraintestinal so-
matic disorders, and (3) psychological/psychiatric disorders, fol-
lowed by a brief discussion of possible common pathophysio-
logical mechanisms that underpin these associations.
IBS and Other Functional 
 Gastrointestinal Disorders
Given the high prevalence of both IBS and functional dis-
orders of the upper gastrointestinal tract, it is not surprising that 
many patients suffer from more than 1 disorder. Probably the 
most common association is the one between IBS and functional 
dyspepsia (FD). A high prevalence of overlap between these 2 
conditions has been consistently reported in numerous studies. In 
a recent meta-analysis, Ford et al.
11 reported the degree of overlap 
to be between 15-42%. Moreover people with dyspepsia had an 
8-fold increase in the prevalence of IBS. Another study that used 
the Rome III criteria found, in 3,014 patients attending a GI 
clinic, that 24.8% of FD patients and 31.5% of IBS patients ful-
filled the diagnostic criteria of the other disorder.
12 In a clin-
ic-based study, Talley et al.
13 found a significant overlap among 
IBS, gastroesophageal reflux disease (GERD), and FD. The 
overlap between IBS and FD was over 80%. In sub-group analy-
ses patients with constipation-predominant IBS had higher rates 
of overlap than patients with diarrhea-predominant IBS.
Furthermore long-term follow ups of patients with IBS and 
FD demonstrate that over time patients with IBS develop FD 
symptoms and vice versa. In a 1-year follow-up, 22% of patients 
with IBS changed their symptom profile from FD to IBS.
14 
These 2 entities also share a similar profile of patients (female IBS and Co-morbidity
115 Vol. 16, No. 2 April, 2010 (113-119)
predominance, high levels of psychological co-morbidities) and 
pathophysiologic mechanisms, mainly visceral hypersensitivity. 
Therefore some argue that the distinction between these 2 entities 
might be artificial and that they actually represent 1 syndrome 
with different clinical presentations.
15
Another common association of IBS is with GERD. 
Nastaskin et al.
16 conducted a systematic review of the literature 
to assess associations between IBS and GERD. They reported 
that the overlap between them is significantly greater than their 
individual prevalence rates and the rates for each disorder would 
be significantly lower if individuals with overlap were removed 
from analyses. Two other population based studies in the United 
States and the United Kingdom reported 25% and 19% overlap 
between IBS and GERD, respectively.
17,18 A population-based 
study found a considerable overlap rate between IBS, FD, and 
GERD. Twenty one percent of IBS patients also had GERD 
symptoms. Patients with symptom overlap demonstrated high 
levels of anxiety compared with patients with only 1 FGID.
19 
Another study found 36 percent prevalence of IBS in GERD 
patients. In addition, the concomitant presence of IBS or psycho-
logical distress in GERD patients predicted higher symptom rat-
ings and lower quality of life before and after PPI treatment, 
making this subset of patients a therapeutic challenge.
20 As in 
functional dyspepsia, visceral hyperalgesia could be a unifying 
underlying mechanism that could explain the high prevalence of 
overlap.
21
IBS and Other Extraintestinal Disorders
Fibromyalgia syndrome (FMS), chronic fatigue syndrome 
(CFS), chronic pelvic pain (CPP), sexual dysfunction, and sleep 
disturbances are non-gastrointestinal functional disorders whose 
associations with IBS have drawn the greatest amount of research 
interest. The studies are consistent in their finding that the over-
lap among these disorders is greater than expected based on their 
separate prevalence rates. In addition, patients with more than 1 
disorder have greater disease severity, higher rates of psychopa-
thology, and more severely impaired health-related quality of life 
than those with only 1 disorder.
4
Inasmuch as the functional disorders overlap significantly 
and have similarities in terms of patient characteristics, impact of 
illness on quality of life, and psychological co-morbidity and 
treatment, it has been suggested that they may represent a group 
of illnesses sharing a common pathogenesis.
22-24 In fact, they are 
so similar in many respects that some authorities have suggested 
that their classification into separate entities is artificial;
25 a result 
of the division of modern medicine into medical sub-specialties. 
This issue will be discussed below. The following sections present 
evidence of associations between IBS and several extraintestinal 
functional disorders.
1. Fibromyalgia syndrome
FMS is a soft tissue disorder characterized by diffuse muscu-
loskeletal pain and specific tender points on examination,
26 with-
out evidence of synovitis or myositis. 
Estimates of the prevalence of IBS in patients with FMS 
range from 30-35%
27 to as high as 70%.
22 Using consensus cri-
teria, our group diagnosed FMS in 31.6% of IBS patients com-
pared to 4.2% of controls. Correspondingly, IBS was diagnosed 
in 32% of women with known FMS.
28 In all clinical and 
health-related variables assessed, including global feeling of well-
being, sleep disturbances, relation of stress to symptoms, physi-
cian visits, concerns about illness, and psychological distress, pa-
tients with both IBS and FMS had more severe disorders than 
those with IBS only. The same pattern held true for the Sense of 
Coherence Index (a measure of coping ability)
29 and the 
Functional Bowel Disorder Severity Index.
30
FMS is considered a disorder of somatic hypersensitivity, 
while IBS is considered a disorder of visceral hypersensitivity. 
Although IBS patients have been reported to have lower, rather 
than higher thresholds for somatic stimulation,
11,12 Chang et al.
31 
reported that female IBS patients with co-morbid FMS have in-
creased sensitivity to somatic stimuli, while those with IBS with-
out FMS show a blunted response. 
2. Chronic fatigue syndrome
The prevalence of CFS in the general population is reported 
to be 0.4%.
32 U p to 70% of FM S pa tients have CFS
33 and 
35-70% of patients with CFS have FMS.
33,34 Studies of IBS 
among CFS patients have reported a prevalence ranging from 
35-92%
34-38 with a median of 51%.
4 The prevalence of IBS 
among patients with CFS is reported to be 14%.
35
Aaron et al.
38 reported the results of a co-twin control study 
of 127 chronic fatigue patients. Co-morbid conditions such as 
FMS, IBS, tempero-mandibular joint pain (TMJ), interstitial 
cystitis, chronic pelvic pain (CPP), tension headache, multiple 
chemical sensitivities, and other functional disorders were sig-
nificantly more prevalent in the twin with CFS than in the 
non-fatigued one. Ami D. Sperber and Roy Dekel
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3. Chronic pelvic pain
The prevalence of CPP in IBS was reported to be 14%.
39 
The rates of IBS in women with CPP are even higher, ranging 
from 29-79%.
39,40 Williams et al.
41 studied 987 new patients re-
ferred to a CPP clinic and reported that 35% met the Rome I cri-
teria for IBS, although IBS was not diagnosed previously in 40% 
of these patients. Longstreth et al.
42 assessed 86 women under-
going gynecological laparoscopy for CPP. IBS was diagnosed in 
47.7% of these women.
The results of studies have shown that a greater awareness of 
IBS on the part of gynecologists could reduce the rate of un-
necessary diagnostic tests and procedures in women complaining 
of pelvic/lower abdominal pain. Because of the similarity in pain 
of bowel and gynecological origin, many IBS patients undergo 
gynecological work-ups, including pelvic laparoscopy for pelvic 
pain, without any pathological findings. 
4.　Sexual dysfunction 
Several studies have reported an increased prevalence of sex-
ual dysfunction among IBS patients, including reduced sexual 
drive,
43 increased dyspareunia,
39,44 and more severe IBS symp-
toms following intercourse. IBS patients report a high rate of in-
tercourse avoidance.
45 IBS symptoms worsen during menses.
46 
The most common sexual dysfunction in IBS patients may be de-
creased libido. Fass et al.
43 reported decreased sexual drive in 
36.2% of male patients and 28.4% of female patients. The preva-
lence of any reported sexual dysfunction among male and female 
patients was 40.6%, which was significantly higher than among 
controls (OR, 4.33; 95% CI, 2.69-7.25; p < 0.001). Among 
women with IBS with a sexual problem over the previous six 
months, 36% reported a decreased sexual drive, 32% reported 
dyspareunia, 32% reported that bowel symptoms directly pre-
vented them from engaging in intercourse, and 15% reported 
that sexual dysfunction worsened directly in relation to the se-
verity of their bowel problems.
Prior et al.
47 evaluated 798 patients referred by general prac-
titioners to a gynecological clinic over a 6 year period. Among the 
63 women who were referred for dyspareunia, 52.4% were found 
to meet diagnostic criteria for IBS (95% CI, 40.8-59.2; p < 
0.001). 
5. IBS and psychological/psychiatric co-morbidity
There is a recognized overlap between IBS and psychiatric 
disorders that involves a large percentage of IBS patients.
48 The 
percentage is particularly high among patients seen in tertiary re-
ferral centers and lower in IBS patients seen and treated in the 
community setting.
49 However, as discussed by North et al.
10 
most IBS patients do not have psychiatric illness per se but do 
manifest psychoform symptoms and somatoform complaints.
Lydiard assessed FGID in 73 panic disorder patients and 
compared these rates to the United States Household Survey.
7 
He reported higher rates of IBS and other FGIDs in these pa-
tients than in the general public.
50 The mean number of FGIDs 
was 3.9 in the panic disorder group, so the co-morbidity encom-
passes many FGIDs and not only IBS.
Gros et al.
51 studied 357 patients with anxiety and depressive 
disorders and found elevated levels of co-morbid IBS symptoms 
in patients with general anxiety disorder (GAD), panic disorder, 
and major depression. Patients who met the Rome II criteria for 
IBS had increased general anxiety compared to those without.
Recently the results of community-based studies have been 
published. Lee et al.
52 studied the co-morbidity of IBS and GAD 
in a community-based sample of 2,005 adolescents and adults 
from Hong Kong. They showed an overall prevalence of 5.4% 
for IBS using the Rome III diagnostic criteria and 4.0% for 
GAD.
52 The OR for IBS was 5.84 among respondents with 
GAD compared to those without GAD and the OR for GAD 
was 6.32 for respondents with IBS compared to those without it 
(both, p < 0.001), showing considerable co-morbidity between 
these disorders.
An aspect of psychiatric co-morbidity that appears to be of 
particular significance in the study of IBS and associated func-
tional disorders is somatization disorder (SD). North et al.
8 re-
ported a very high rate of non-gastrointestinal functional dis-
orders in IBS patients, but significantly more so among those 
with SD. They reported that many aspects of co-morbidity and 
health care behaviors were more associated with the diagnosis of 
SD than with the diagnosis of IBS. In fact SD was much more 
important that depression or anxiety, which are often considered 
as psychiatric associates of IBS. This may not be surprising given 
that SD is defined, in part, as the manifestation of multiple symp-
toms across different organ systems. 
Whitehead et al. have suggested that IBS patients with other 
co-morbid functional disorders manifest a greater degree of so-
matization, which may serve as a link between these disorders and 
increased health care utilization, disability, and impaired quality 
of life.
54 They propose that the presence of multiple co-morbid 
disorders is a marker for psychological influences on etiology.
4 
This link has potential therapeutic ramifications.IBS and Co-morbidity
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6.　One syndrome, or many?
In the mid 19th century Beard,
55 an American neurologist, 
published a paper on “neurasthenia”, a term he used to describe 
individuals with unexplained chronic fatigue and lassitude 
(nervous exhaustion). He noted that these patients had additional 
symptoms including sleep difficulties, back pain, nervousness, 
anxiety, depression, headache, difficulty in concentrating, re-
duced sexual impulse, abdominal pain, bloating and excess gas, 
diarrhea, and lack of appetite. Although he described patients of 
both sexes, he reported a female predominance. The patients he 
described might be diagnosed today with CFS, or depending on 
the specialist that saw them, any of the other system-specific func-
tional disorders.
Others have suggested that the disorders may be related 
through their association with depression and have suggested 
classifying them as a single entity called the “affective spectrum 
disorder.”
24,56 However, Henningsen et al.
57 performed a 
meta-analysis on the association between medically unexplained 
physical symptoms, anxiety, and depression and concluded that 
while IBS, FMS, and CFS are associated with anxiety and de-
pression, they are not dependent on these psychological di-
mensions and cannot be classified as “common mental disorders.” 
Still, as discussed above, SD is a potentially important link be-
tween the various functional disorders.
So are the functional disorders 1 syndrome or many? The ju-
ry is still out on this intriguing issue. While the name of the syn-
drome may be determined by the specialist who sees the patient, 
as has been suggested and discussed above, a more relevant ques-
tion may be why did the patient see that particular specialist? In 
our experience, patients who meet the diagnostic criteria for sev-
eral functional disorders often manifest 1 disorder clinically much 
more that the others and seek consultation differentially for that 
set of symptoms. Thus, a patient could be diagnosed formally 
with CPP, IBS, FMS, and TMJ, but judging by their con-
sultation pattern might be considered a patient of 1 syndrome and 
a non-patient in the others. For example, a patient diagnosed with 
both IBS and FMS might be an IBS-patient and an FMS 
non-patient, or an FMS-patient and an IBS non-patient. In the 
first instance they would likely consult a gastroenterologist and in 
the second a rheumatologist. Our clinical impression is that many 
patients with more that 1 formal diagnosis do not consult multiple 
specialists, but concentrate on the physician who specializes in the 
symptoms that they suffer from in particular. 
In this respect it is interesting that Wessely, who was the first 
author of the paper that discussed the potentially artifactual sepa-
ration of functional syndromes into separate entities,
25 states in a 
2007 paper that: “In the functional somatic disorders, a diagnosis 
that represents the patient’s view of his/her illness stands to be 
both instrumentally and pragmatically apt.”
58 This would seem to 
be particularly appropriate for disorders that are diagnosed on the 
basis of patients’ subjective symptom reports rather than on the 
basis of objective tests.
In summary, many IBS patients have at least 1 co-morbid so-
matic complaint and many of them meet diagnostic criteria for 
other gastrointestinal and extraintestinal functional disorders. 
Patients with IBS and 1 or more other functional disorders, in 
comparison with patients with IBS only, have more severe IBS 
symptoms, a higher rate of psychopathology such as depression, 
anxiety and somatization, and a greater impairment of quality of 
life.
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